Solara Active Pharma Sciences Limited (NSE: Solara) Q4’26 Earnings Update: Strong Momentum in Base Business Despite Ibuprofen Headwinds

Solara Active Pharma Sciences Limited (NSE: SOLARA) reports strong Q4’26 earnings with 40% YoY growth, driven by robust base business despite challenges in Ibuprofen segment.